中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
27期
6-8
,共3页
周小青%欧阳娟%刘晓平%叶军明%曾桂芳%杨斌%张国辉%叶斌
週小青%歐暘娟%劉曉平%葉軍明%曾桂芳%楊斌%張國輝%葉斌
주소청%구양연%류효평%협군명%증계방%양빈%장국휘%협빈
直肠癌%淋巴结%GCC mRNA%预后
直腸癌%淋巴結%GCC mRNA%預後
직장암%림파결%GCC mRNA%예후
Rectal cancer%Lymph nodes%GCC mRNA%Prognosis
目的:探讨GCC mRNA在淋巴结阴性(pN0)直肠癌患者淋巴结中表达与预后的关系。方法:应用RT-PCR检测60例pN0直肠癌淋巴结中GCC mRNA表达水平,并分为GCC mRNA阳性组(pN0(mol+))16例与阴性组(pN0(mol-))44例。分析两组患者的局部复发率、远处转移率、无瘤生存期(DFS)与GCC mRNA表达水平的关系。结果:GCC mRNA阴性组的局部复发率及远处转移率更低(P<0.05),无瘤生存期更长(P<0.05);TNM分期中T3~T4淋巴结GCC mRNA表达阳性率明显高于T1~T2(P<0.05)。结论:GCC mRNA表达水平与患者的预后密切相关,提示GCC mRNA可作为直肠癌淋巴结微转移的有效分子学检测指标。
目的:探討GCC mRNA在淋巴結陰性(pN0)直腸癌患者淋巴結中錶達與預後的關繫。方法:應用RT-PCR檢測60例pN0直腸癌淋巴結中GCC mRNA錶達水平,併分為GCC mRNA暘性組(pN0(mol+))16例與陰性組(pN0(mol-))44例。分析兩組患者的跼部複髮率、遠處轉移率、無瘤生存期(DFS)與GCC mRNA錶達水平的關繫。結果:GCC mRNA陰性組的跼部複髮率及遠處轉移率更低(P<0.05),無瘤生存期更長(P<0.05);TNM分期中T3~T4淋巴結GCC mRNA錶達暘性率明顯高于T1~T2(P<0.05)。結論:GCC mRNA錶達水平與患者的預後密切相關,提示GCC mRNA可作為直腸癌淋巴結微轉移的有效分子學檢測指標。
목적:탐토GCC mRNA재림파결음성(pN0)직장암환자림파결중표체여예후적관계。방법:응용RT-PCR검측60례pN0직장암림파결중GCC mRNA표체수평,병분위GCC mRNA양성조(pN0(mol+))16례여음성조(pN0(mol-))44례。분석량조환자적국부복발솔、원처전이솔、무류생존기(DFS)여GCC mRNA표체수평적관계。결과:GCC mRNA음성조적국부복발솔급원처전이솔경저(P<0.05),무류생존기경장(P<0.05);TNM분기중T3~T4림파결GCC mRNA표체양성솔명현고우T1~T2(P<0.05)。결론:GCC mRNA표체수평여환자적예후밀절상관,제시GCC mRNA가작위직장암림파결미전이적유효분자학검측지표。
Objective:To explore the relationship between GCC mRNA expression of lymph nodes and prognosis in patients with pN0 rectal cancer.Method:The expression of GCC mRNA in lymph nodes of 60 pN0 rectal cancer patients were detected by RT-PCR method,they were divided into the GCC mRNA positive group(pN0(mol+))for 16 cases and the negative groups(pN0(mol))for 44 cases. The relationship between local recurrence,distant metastasis rate, disease-free survival(DFS)and GCC mRNA expression levels of the two groups were analyzed.Result:The GCC mRNA negative group had lower local recurrence and distant metastasis rate(P<0.05),and longer disease-free survival(P<0.05). Conclusion:Lymph node GCC mRNA expression level is closely related to the prognosis of rectal cancer patient. It can be used as an effective molecular marker in lymph node micrometastase of rectal cancer.